Bifid nose

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2695OMIM:109740Q30.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bifid nose (also known as cleft nose, nasal cleft, or median nasal cleft) is a rare congenital malformation characterized by a partial or complete vertical splitting of the nose along the midline. This condition results from incomplete fusion of the nasal placodes during embryonic development, typically between the fourth and eighth weeks of gestation. The severity can range from a minor midline groove or notch at the nasal tip to a complete separation of the two nasal halves with widely spaced nostrils and a broad nasal bridge. In more severe forms, the underlying nasal cartilage and bone may also be cleft, and the condition may be associated with a widened nasal dorsum, hypertelorism (widely spaced eyes), or a midline dermoid cyst. Bifid nose can occur as an isolated anomaly or as part of broader syndromic conditions, including frontonasal dysplasia, Pai syndrome, or other midline developmental defects. When syndromic, additional features may include midline cleft lip, cranium bifidum occultum, intracranial lipomas, or other craniofacial anomalies. The body systems primarily affected are the craniofacial structures, particularly the nose and midface. Respiratory function may be impacted in severe cases due to structural abnormalities of the nasal passages. Treatment is primarily surgical and aims to reconstruct the nose for both functional and cosmetic purposes. Surgical repair typically involves rhinoplasty techniques to bring the separated nasal halves together, reconstruct the nasal framework, and achieve a more typical nasal appearance. The timing and complexity of surgery depend on the severity of the defect and whether associated anomalies are present. Multidisciplinary care involving craniofacial surgeons, otolaryngologists, and geneticists is often recommended, particularly in syndromic cases. Outcomes are generally favorable with appropriate surgical intervention, though multiple procedures may be needed as the child grows.

Clinical phenotype terms— hover any for plain English:

Bifid noseHP:0011803
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Bifid nose.

View clinical trials →

No actively recruiting trials found for Bifid nose at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bifid nose community →

Specialists

1 foundView all specialists →
BG
Berceste Güler
Specialist
PI on 2 active trials5 Bifid nose publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bifid nose.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bifid noseForum →

No community posts yet. Be the first to share your experience with Bifid nose.

Start the conversation →

Latest news about Bifid nose

No recent news articles for Bifid nose.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Bifid nose

What is Bifid nose?

Bifid nose (also known as cleft nose, nasal cleft, or median nasal cleft) is a rare congenital malformation characterized by a partial or complete vertical splitting of the nose along the midline. This condition results from incomplete fusion of the nasal placodes during embryonic development, typically between the fourth and eighth weeks of gestation. The severity can range from a minor midline groove or notch at the nasal tip to a complete separation of the two nasal halves with widely spaced nostrils and a broad nasal bridge. In more severe forms, the underlying nasal cartilage and bone may

At what age does Bifid nose typically begin?

Typical onset of Bifid nose is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Bifid nose?

1 specialists and care centers treating Bifid nose are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.